Document Detail


Patient characteristics and process factors associated with antipsychotic polypharmacy in a nationwide sample of psychiatric inpatients in Italy.
MedLine Citation:
PMID:  21523847     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
PURPOSE: The present study investigated: (i) the rate of prescription of antipsychotic (AP) polypharmacy (APP) in a large, representative sample of psychiatric inpatients; and (ii) the relationship between APP prescription and the characteristics of patients and facilities.
METHODS: The sample included 1022 psychiatric patients scheduled to be discharged from acute inpatient facilities with drug therapies including AP. Demographic and clinical data were obtained from the treating physician or retrieved from patients' records through a standardized Patient Form. Patients were administered the 24-item Brief Psychiatric Rating Scale. Three indicators were used to describe the process of care in the facilities: a Restrictiveness score, a Standardization score, and a Treatment score. A multilevel mixed-effect logistic regression was used to predict APP using patient and facility as the variables.
RESULTS: APP was prescribed to 333 (32.5%) patients, the most common patterns being a first-generation and a second-generation AP (n = 178, 17.6%) or of two first-generation APs (n = 80, 7.8%). Patients with a diagnosis of schizophrenia and poorer insight into illness at admission were significantly more likely to receive APP. The availability of more complex therapeutic interventions in the facility was also associated with APP.
CONCLUSIONS: In our nationwide sample of psychiatric inpatients, APP was frequently prescribed to treat the more severe patients. However, it was also associated with process of care characteristics such as delivery of more complex therapeutic interventions, and was therefore not used only to control patient behavior. Copyright © 2010 John Wiley & Sons, Ltd.
Authors:
Giovanni Santone; Cesario Bellantuono; Paola Rucci; Angelo Picardi; Antonio Preti; Giovanni de Girolamo
Related Documents :
21237167 - An alerting system improves adherence to follow-up recommendations from colonoscopy exa...
21248437 - A brief review of voice restoration following total laryngectomy.
21411047 - [dermatomyositis: assessment and follow-up of 20 patients].
21297087 - Jarisch-herxheimer reaction among syphilis patients in rio de janeiro, brazil.
3752727 - Use of absorbable collagen for hemostasis in general surgical patients.
2055077 - Intensive care unit patients with acquired immunodeficiency syndrome and pneumocystis c...
Publication Detail:
Type:  Journal Article     Date:  2010-12-23
Journal Detail:
Title:  Pharmacoepidemiology and drug safety     Volume:  20     ISSN:  1099-1557     ISO Abbreviation:  Pharmacoepidemiol Drug Saf     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-04-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9208369     Medline TA:  Pharmacoepidemiol Drug Saf     Country:  England    
Other Details:
Languages:  eng     Pagination:  441-9     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 John Wiley & Sons, Ltd.
Affiliation:
Psychiatric Unit, United Hospitals of Ancona and Polytechnic University of Marche, Ancona, Italy. g.santone@ospedaliriuniti.marche.it.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evidence for treatment strategies in sinonasal adenocarcinoma.
Next Document:  Prevalence, incidence and persistence of etanercept and adalimumab in Norway 2005-2009.